Disclosed positions

Estimated from their latest filings — positions may have changed since

$5.00M

combined est. value

Stock	Shares	Price	Value	Weight	As of
SRPTSarepta Therapeutics, Inc.	214,357	$19.28	$4.13M	83%	2026-06-04
MDXGMIMEDX GROUP, INC.	212,771	$4.07	$866.0K	17%	2025-06-18

SRPT

Sarepta Therapeutics, Inc.

$4.13M

214,357 sh

MDXG

MIMEDX GROUP, INC.

$866.0K

212,771 sh

All filings on record

Every Form 4 transaction we track for this filer

all 9buys 0sells 0

Stock	Transaction	Date	~6mo later
SRPTSarepta Therapeutics, Inc.	Grant — · 16,875 sh	2026-06-04	—
SRPTSarepta Therapeutics, Inc.	Tax $144.0K · 6,494 sh	2026-01-27	—
SRPTSarepta Therapeutics, Inc.	Exercise $144.0K · 10,500 sh	2026-01-27	—
IGMSIGM Biosciences, Inc.	Return — · 29,806 sh	2025-08-14	—
IGMSIGM Biosciences, Inc.	Return — · 29,807 sh	2025-08-14	—
IGMSIGM Biosciences, Inc.	Return — · 330,700 sh	2025-08-14	—
IGMSIGM Biosciences, Inc.	Return — · 22,222 sh	2025-08-14	—
IGMSIGM Biosciences, Inc.	Grant — · 1,471 sh	2025-06-30	—
MDXGMIMEDX GROUP, INC.	Grant $185.1K · 28,609 sh	2025-06-18	—

SRPTGrant

2026-06-04 · Sarepta Therapeutics, Inc.

16,875

—

SRPTTax

2026-01-27 · Sarepta Therapeutics, Inc.

$144.0K

—

SRPTExercise

2026-01-27 · Sarepta Therapeutics, Inc.

$144.0K

—

IGMSReturn

2025-08-14 · IGM Biosciences, Inc.

29,806

—

IGMSReturn

2025-08-14 · IGM Biosciences, Inc.

29,807

—

IGMSReturn

2025-08-14 · IGM Biosciences, Inc.

330,700

—

IGMSReturn

2025-08-14 · IGM Biosciences, Inc.

22,222

—

IGMSGrant

2025-06-30 · IGM Biosciences, Inc.

1,471

—

MDXGGrant

2025-06-18 · MIMEDX GROUP, INC.

$185.1K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.